Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

The age at which cancer survivors are diagnosed with their disease may help predict their risk of death from cardiac disease

Age at Cancer Diagnosis Key in Determining Later Cardiac Risk

The younger the age at diagnosis, the greater the risk, study suggests
Despite three decades of advancements in treating children with cancer

Long-Term Health Not Improved for Childhood Cancer Survivors

Those treated in 1990s more likely to report pain and poor health as adults, researchers say

World Cancer Congress, Oct. 31-Nov. 3

The 2016 World Cancer Congress The biennial meeting of the Union for International Cancer Control, the World Cancer Congress, was held from Oct....
The American Society of Clinical Oncology Clinical Practice Guideline on the integration of palliative care into standard oncology care has been updated. The update was published online Oct. 28 in the Journal of Clinical Oncology.

ASCO Updates Guidelines on Integration of Palliative Care

Those with advanced cancer should receive dedicated palliative care services early in disease course

October 2016 Briefing – Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for October 2016. This roundup includes...
Treatment for depression and anxiety is nearly twice as common among U.S. cancer survivors as it is for those with no history of cancer

Cancer Survivors Have Higher Rate of Antidepressant Use

Nearly one in five survivors taking medication for depression or anxiety years later
For patients with type 2 diabetes mellitus

Statins Offset Insulin-Related Cancer Risk in T2DM

Risks of cancer reduced with statins; greater risk reduction in those not receiving antihyperglycemic tx
Nearly one-third of cancer deaths among Americans aged 35 or older are caused by smoking

Smoking Still Responsible for Many U.S. Cancer Deaths

Linked to close to one-third of fatal cancers in patients 35 and older
Financial toxicity is a clinically relevant outcome for patients receiving treatment for advanced cancer

Financial Toxicity Is a Relevant Cancer Outcome Measure

Health-related quality of life correlated with financial toxicity in cancer patients
Lartruvo (olaratumab) has been approved by the U.S. Food and Drug Administration to treat adults with certain soft tissue sarcomas.

FDA Approves New Treatment for Advanced Soft Tissue Sarcoma

Sanctioned for use with doxorubicin in cases that cannot be treated with radiation or surgery